z-logo
open-access-imgOpen Access
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
Author(s) -
Doron Yablecovitch,
Shomron BenHorin,
Orit Picard,
Miri Yavzori,
Ella Fudim,
Moshe Nadler,
Idan Levy,
Emad Sakhnini,
Alon Lang,
Tal Engel,
Maor Lahav,
Talia Saker,
Sandra Neuman,
Limor Selinger,
Revital Dvir,
Maria RaitsesGurevich,
Talia Golan,
Ido Laish
Publication year - 2022
Publication title -
clinical and translational gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.673
H-Index - 35
ISSN - 2155-384X
DOI - 10.14309/ctg.0000000000000473
Subject(s) - pancreatic ductal adenocarcinoma , medicine , biomarker , adenocarcinoma , syndecan 1 , pancreatic cancer , oncology , pathology , cancer research , cancer , biology , biochemistry , genetics , cell

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here